×
About 75,590 results

AllMedicine All Center

Research & Reviews  36,295 results

FDA Grants Genentech’s Tecentriq in Combination With Abraxane Accelerated Approval for People With PD-L1-Positive, Metastatic Triple-Negative Breast Cancer
https://www.marketwatch.com/press-release/fda-grants-genentechs-tecentriq-in-combination-with-abraxane-accelerated-approval-for-people-with-pd-l1-positive-metastatic-triple-negative-breast-cancer-2019-03-08

Mar 7th, 2019 - Genentech, a member of the Roche Group (six:RO)(six:ROG)(otcqx:RHHBY), today announced the U.S. Food and Drug Administration (FDA) has granted accelerated approval to Tecentriq [®] (atezolizumab) plus chemotherapy (Abraxane [®] [paclitaxel protein...

Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes—2019
http://care.diabetesjournals.org/content/42/Supplement_1/S124

Dec 17th, 2018 - Chronic kidney disease (CKD) is diagnosed by the persistent presence of elevated urinary albumin excretion (albuminuria), low estimated glomerular filtration rate (eGFR), or other manifestations of kidney damage (1,2). In this section, the focus w...

Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
https://www.nejm.org/doi/10.1056/NEJMoa1809615
Schmid, P. et. al.

Nov 28th, 2018 - Unresectable locally advanced or metastatic triple-negative (hormone-receptor–negative and human epidermal growth factor receptor 2 [HER2]–negative) breast cancer is an aggressive disease with poor outcomes. Nanoparticle albumin-bound (nab)–paclit...

Home Use Tests
https://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/InVitroDiagnostics/HomeUseTests/default.htm

Sep 26th, 2018 - Home use tests allow you to test for some diseases or conditions at home. These tests are cost-effective, quick, and confidential. Home use tests can help: detect possible health conditions when you have no symptoms, so that you can get early t...

Liver Structure and Function - Hepatic and Biliary Disorders - Merck Manuals Professional Edition
https://www.merckmanuals.com/professional/hepatic-and-biliary-disorders/approach-to-the-patient-with-liver-disease/liver-structure-and-function

Jan 1st, 2018 - The liver is the most metabolically complex organ. Hepatocytes (liver parenchymal cells) perform the liver’s metabolic functions: Formation and excretion of bile during bilirubin metabolism (see Overview of Bilirubin Metabolism) Regulation of ...

see more →

Guidelines  35 results

FDA Grants Genentech’s Tecentriq in Combination With Abraxane Accelerated Approval for People With PD-L1-Positive, Metastatic Triple-Negative Breast Cancer
https://www.marketwatch.com/press-release/fda-grants-genentechs-tecentriq-in-combination-with-abraxane-accelerated-approval-for-people-with-pd-l1-positive-metastatic-triple-negative-breast-cancer-2019-03-08

Mar 7th, 2019 - Genentech, a member of the Roche Group (six:RO)(six:ROG)(otcqx:RHHBY), today announced the U.S. Food and Drug Administration (FDA) has granted accelerated approval to Tecentriq [®] (atezolizumab) plus chemotherapy (Abraxane [®] [paclitaxel protein...

Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes—2019
http://care.diabetesjournals.org/content/42/Supplement_1/S124

Dec 17th, 2018 - Chronic kidney disease (CKD) is diagnosed by the persistent presence of elevated urinary albumin excretion (albuminuria), low estimated glomerular filtration rate (eGFR), or other manifestations of kidney damage (1,2). In this section, the focus w...

Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
https://www.nejm.org/doi/10.1056/NEJMoa1809615
Schmid, P. et. al.

Nov 28th, 2018 - Unresectable locally advanced or metastatic triple-negative (hormone-receptor–negative and human epidermal growth factor receptor 2 [HER2]–negative) breast cancer is an aggressive disease with poor outcomes. Nanoparticle albumin-bound (nab)–paclit...

Home Use Tests
https://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/InVitroDiagnostics/HomeUseTests/default.htm

Sep 26th, 2018 - Home use tests allow you to test for some diseases or conditions at home. These tests are cost-effective, quick, and confidential. Home use tests can help: detect possible health conditions when you have no symptoms, so that you can get early t...

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C
https://www.hcvguidelines.org/

May 23rd, 2018 - New direct-acting oral agents capable of curing hepatitis C virus (HCV) infection have been approved for use in the United States. The initial direct-acting agents were approved in 2011, and many more oral drugs are expected to be approved in the.

see more →

Drugs  109 results see all →

Clinicaltrials.gov  37,619 results

FDA Grants Genentech’s Tecentriq in Combination With Abraxane Accelerated Approval for People With PD-L1-Positive, Metastatic Triple-Negative Breast Cancer
https://www.marketwatch.com/press-release/fda-grants-genentechs-tecentriq-in-combination-with-abraxane-accelerated-approval-for-people-with-pd-l1-positive-metastatic-triple-negative-breast-cancer-2019-03-08

Mar 7th, 2019 - Genentech, a member of the Roche Group (six:RO)(six:ROG)(otcqx:RHHBY), today announced the U.S. Food and Drug Administration (FDA) has granted accelerated approval to Tecentriq [®] (atezolizumab) plus chemotherapy (Abraxane [®] [paclitaxel protein...

Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes—2019
http://care.diabetesjournals.org/content/42/Supplement_1/S124

Dec 17th, 2018 - Chronic kidney disease (CKD) is diagnosed by the persistent presence of elevated urinary albumin excretion (albuminuria), low estimated glomerular filtration rate (eGFR), or other manifestations of kidney damage (1,2). In this section, the focus w...

Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
https://www.nejm.org/doi/10.1056/NEJMoa1809615
Schmid, P. et. al.

Nov 28th, 2018 - Unresectable locally advanced or metastatic triple-negative (hormone-receptor–negative and human epidermal growth factor receptor 2 [HER2]–negative) breast cancer is an aggressive disease with poor outcomes. Nanoparticle albumin-bound (nab)–paclit...

Home Use Tests
https://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/InVitroDiagnostics/HomeUseTests/default.htm

Sep 26th, 2018 - Home use tests allow you to test for some diseases or conditions at home. These tests are cost-effective, quick, and confidential. Home use tests can help: detect possible health conditions when you have no symptoms, so that you can get early t...

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C
https://www.hcvguidelines.org/

May 23rd, 2018 - New direct-acting oral agents capable of curing hepatitis C virus (HCV) infection have been approved for use in the United States. The initial direct-acting agents were approved in 2011, and many more oral drugs are expected to be approved in the.

see more →

News  1,473 results

FDA Grants Genentech’s Tecentriq in Combination With Abraxane Accelerated Approval for People With PD-L1-Positive, Metastatic Triple-Negative Breast Cancer
https://www.marketwatch.com/press-release/fda-grants-genentechs-tecentriq-in-combination-with-abraxane-accelerated-approval-for-people-with-pd-l1-positive-metastatic-triple-negative-breast-cancer-2019-03-08

Mar 7th, 2019 - Genentech, a member of the Roche Group (six:RO)(six:ROG)(otcqx:RHHBY), today announced the U.S. Food and Drug Administration (FDA) has granted accelerated approval to Tecentriq [®] (atezolizumab) plus chemotherapy (Abraxane [®] [paclitaxel protein...

Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes—2019
http://care.diabetesjournals.org/content/42/Supplement_1/S124

Dec 17th, 2018 - Chronic kidney disease (CKD) is diagnosed by the persistent presence of elevated urinary albumin excretion (albuminuria), low estimated glomerular filtration rate (eGFR), or other manifestations of kidney damage (1,2). In this section, the focus w...

Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
https://www.nejm.org/doi/10.1056/NEJMoa1809615
Schmid, P. et. al.

Nov 28th, 2018 - Unresectable locally advanced or metastatic triple-negative (hormone-receptor–negative and human epidermal growth factor receptor 2 [HER2]–negative) breast cancer is an aggressive disease with poor outcomes. Nanoparticle albumin-bound (nab)–paclit...

Home Use Tests
https://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/InVitroDiagnostics/HomeUseTests/default.htm

Sep 26th, 2018 - Home use tests allow you to test for some diseases or conditions at home. These tests are cost-effective, quick, and confidential. Home use tests can help: detect possible health conditions when you have no symptoms, so that you can get early t...

Liver Structure and Function - Hepatic and Biliary Disorders - Merck Manuals Professional Edition
https://www.merckmanuals.com/professional/hepatic-and-biliary-disorders/approach-to-the-patient-with-liver-disease/liver-structure-and-function

Jan 1st, 2018 - The liver is the most metabolically complex organ. Hepatocytes (liver parenchymal cells) perform the liver’s metabolic functions: Formation and excretion of bile during bilirubin metabolism (see Overview of Bilirubin Metabolism) Regulation of ...

see more →

Patient Education  59 results see all →